The trademark application VICEOLIS was filed by Vicore Pharma AB, a corporation established under the laws of the Kingdom of Sweden (the "Applicant"). The application was published for oppositions on August 1, 2021, and it was registered by office on November 8, 2021 without any oppositions.
It was designated 'Basic Application' for International Application 1631334 at the World Intellectual Property Organization (WIPO).
The application was filed in Swedish (English was selected as the second language).
Change of name and professional address of the trademark registration was recorded on December 12, 2021.
Goods And Services
The mark was filed in class 5 with following description of goods:
Pharmaceuticals and medical preparations for human use
Pharmaceutical preparations within the fields of pulmonary diseases, cardiovascular diseases, autoimmune and inflammatory diseases, fibrotic diseases and kidney diseases
Pharmaceutical preparations for pulmonary fibrosis namely IPF
Pharmaceutical preparations for diffuse systemic sclerosis (lung manifestations)
Pharmaceutical preparations for infectious lung diseases